Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth's revenue increased in the first quarter of fiscal 2024. It reduced its losses significantly in the first quarter.

Canopy Growth Stock: Bear vs. Bull

Hershey

Canopy Growth Corp.'s CGC, -0.39% U.S.-listed stock fell 1% after the company said it agreed to sell its Hershey Drive facility in Smiths Falls, Ontario to Hershey Co. HSY, -0.56% for C$53 million ($39.3 million). The company will still own its post-harvest manufacturing facility in Smiths Falls.

Canopy Growth selling Smiths Falls facility to Hershey

Facility will be sold to Hershey Canada, Inc. for approximately CAD$53 million Canopy Growth continues to execute on transformation to simplified, asset-light operating model SMITHS FALLS, ON , Aug. 17, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) announced today that it has entered into an agreement (the "Agreement") to sell its Hershey Drive facility (the "Facility") in Smiths Falls, Ontario, as part of the Company's transformation to a simplified, asset-light operating model. Canopy Growth will retain its Smiths Falls-based post-harvest manufacturing facility.

Canopy Growth Enters into an Agreement for the Sale of Hershey Drive Facility in Smiths Falls

Canopy Growth didn't have any mammoth impairment charges weighing down its business this past quarter. Revenue growth, however, remains a challenge as many of the company's segments posted underwhelming numbers.

Canopy Growth Significantly Shrinks Its Loss in Q1: Is Now the Time to Buy?

The Canadian pot purveyor had an uninspiring start to its new fiscal year. Even though it improved key fundamentals, it remains deeply in the red on the bottom line.

Why Canopy Growth Stock Tanked on Thursday

Curaleaf Holdings, Inc.

Canopy Growth Inc. disclosed another quarterly loss but managed to beat analysts' expectations as its efforts to contain costs in its Canadian business start to pay off.

Canopy Growth beats analyst targets as its ‘asset-light' strategy bears fruit, but Curaleaf's miss weighs on pot stocks

OrganiGram Holdings Inc.

Tilray Brands

In August 2023, the Canadian cannabis sector and top marijuana stocks attracted the attention of many investors. The quarterly cannabis earnings season has begun, providing light on the financial performance and growth prospects of Canada's biggest cannabis companies. This critical juncture offers investors a unique chance to examine the industry's current picture and contemplate strategic holdings in leading Canadian cannabis stocks. With the cannabis industry quickly expanding, knowledgeable traders are navigating the subtleties of short- and long-term trading methods while utilizing technical analysis to maximize entry and exit points.

Top Canadian Cannabis Stocks To Watch In August 2023

Canopy Growth Corporation (NASDAQ:CGC ) Q1 2024 Results Conference Call August 9, 2023 5:30 PM ET Company Participants Tyler Burns - Director, IR David Klein - CEO Judy Hong - CFO Conference Call Participants Vivien Azer - TD Cowen Aaron Grey - Alliance Global Partners Michael Lavery - Piper Sandler John Zamparo - CIBC Operator Good afternoon. My name is Michelle and I will be your conference operator today.

Canopy Growth Corporation (CGC) Q1 2024 Earnings Call Transcript

Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.10. This compares to loss of $0.70 per share a year ago.

Canopy Growth Corporation (CGC) Reports Q1 Loss, Tops Revenue Estimates

Net revenue in Q1 FY2024 increased 3% year-over-year to $109 million. Adjusting for divestiture of Canadian cannabis retail operations in FY2023, Q1 FY2024 net revenue increased 16% year-over-year Achieved total cost savings of $172 million through Q1 FY2024 Management reaffirms its expectation to achieve positive Adjusted EBITDA in all business units exiting FY2024, with the exception of BioSteel SMITHS FALLS, ON , Aug. 9, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (Nasdaq: CGC) today announces its financial results for the first quarter ended June 30, 2023.

Canopy Growth Reports First Quarter Fiscal Year 2024 Financial Results

Cronos Group

The cannabis industry has captivated both investors and consumers in recent years. Amidst its diversity, certain standout companies have made their mark by prioritizing people's well-being and striving for sustainable growth.

3 Reasons Why Investors Are Lighting Up Cannabis Stocks Again

Canopy Growth's cash burn rate is crippling. The company may need to sell shares or debt to raise cash.

1 Big Reason to Stay Far Away From Canopy Growth Stock

How long are marijuana stock investors going to hold on? What this means is much of the cannabis sector has an unpredictable way of performing. For example, there is no way to tell or be truly sure when cannabis stock will rise. At one point in time essentially any positive casualty would help bring trading up. For some time that has not been the case so what keeps investors so interested? Well, not all are as confident as others but with how young the cannabis industry still is there is much to stay optimistic about.

3 Marijuana Stocks To Watch First Week Of August

The fascinating world of cannabis! In recent years, this exciting sector has attracted the interest of investors and consumers alike.

3 Cannabis Stocks to Buy Before the Breakout

Canopy Growth's revenue growth has turned negative. The situation isn't improving, and that's putting pressure on other areas of its financials.

Canopy Growth's Struggles in 4 Charts

SMITHS FALLS, ON , July 26, 2023 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the first quarter fiscal year 2024 ended June 30, 2023 after markets close on August 9, 2023. Following the release of its first quarter fiscal year 2024 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO on August 9, at 5:30 PM Eastern Time.

Canopy Growth to Report First Quarter Fiscal 2024 Financial Results on August 9, 2023

Strong demand for legal cannabis products in the Canadian recreational cannabis market and the launch of new products are expected to have driven Canopy Growth's (CGC) Q1 performance.

What's in Store for Canopy Growth (CGC) in Q1 Earnings?

Aurora Cannabis

Neptune Wellness Solutions Inc.

Looking for the best marijuana stocks to buy in 2023? It's crucial to consider the risks associated with the cannabis industry. For example things like regulatory uncertainties, legal changes, and market volatility. As well as operational challenges. Also stay updated with industry news, tracking relevant sources, and monitoring regulatory updates.

3 Canadian Marijuana Stocks To Watch Today 2023

NEW YORK , July 24, 2023 /PRNewswire/ -- Attention Canopy Growth Corporation ("Canopy Growth") (NASDAQ: CGC) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between June 1, 2021 and May 10, 2023. If you suffered a loss on your investment in Canopy Growth, contact us about potential recovery by using the link below.

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Canopy Growth Investors of a Lead Plaintiff Deadline of July 24, 2023

NEW YORK , July 22, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Canopy Growth Corporation (NASDAQ: CGC) between June 1, 2021 and May 10, 2023, both dates inclusive (the "Class Period"), of the important July 24, 2023 lead plaintiff deadline. SO WHAT: If you purchased Canopy Growth securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

CGC MONDAY DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages Canopy Growth Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important July 24 Deadline in Securities Class Action - CGC

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming July 24, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Canopy Growth Corporation (“Canopy Growth” or the “Company”) (NASDAQ: CGC) securities between May 31, 2022 and May 10, 2023, inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. On May 10, 2023, after the market closed, Canopy Growth.

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Canopy Growth Corporation (CGC)

NEW YORK , July 21, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Canopy Growth Corporation (NASDAQ: CGC). To receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/canopy-growth-class-action-loss-submission-form/?id=42374&from=4 The lawsuit seeks to recover losses for shareholders who purchased Canopy Growth between June 1, 2021 and May 10, 2023.

CGC SHAREHOLDER ALERT: Jakubowitz Law Reminds Canopy Growth Shareholders of a Lead Plaintiff Deadline of July 24, 2023

BENSALEM, Pa. , July 20, 2023 /PRNewswire/ -- Law Offices of Howard G.

CGC Investors Have Opportunity to Lead Canopy Growth Corporation Securities Fraud Lawsuit

Certification reinforces STORZ & BICKEL's leadership position in medical device design, ensures continued availability of devices worldwide TUTTLINGEN, Germany , July 20, 2023 /PRNewswire/ - STORZ & BICKEL GmbH ("STORZ & BICKEL"), the world-leading manufacturer of high-end and medically certified cannabis vaporizers and subsidiary of Canopy Growth Corporation (TSX: WEED) (Nasdaq: CGC), today announced the certification of its premium VOLCANO MEDIC 2 and the MIGHTY+ MEDIC, in accordance with the new EU Medical Device Regulations ("MDR"). The new MDR regulations outline stricter quality requirements for medical devices manufactured in or imported to the EU than its predecessor, the MDD (Medical Devices Directive).

STORZ & BICKEL Announces Certification of Medical Vaporizers Under New EU Medical Device Regulations

NEW YORK , July 20, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Canopy Growth Corporation ("Canopy Growth" or the "Company") (NASDAQ: CGC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Canopy Growth investors who were adversely affected by alleged securities fraud between June 1, 2021 and May 10, 2023.

News for Canopy Growth Stock (CGC)